Selenium-containing histone deacetylase inhibitors for melanoma management

Histone Deacetylase Inhibitors: Design, Structure-Activity Relationships and Therapeutic Implications for Cancer

(2012) Charles Marson   Anti-Cancer Agents in Medicinal Chemistry

Targeting sphingosine kinase-1 to inhibit melanoma

(2012) SubbaRao V. Madhunapantula et al.   Pigment Cell & Melanoma Research

Melanoma Prevention Using Topical PBISe

(2011) C.-Y. Chung et al.   Cancer Prevention Research

Vorinostat: A novel therapy for the treatment of cutaneous T-cell lymphoma: Figure 1

(2010) Shannon A. Kavanaugh et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Selenium-containing analogs of SAHA induce cytotoxicity in lung cancer cells

(2010) Nilkamal Karelia et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Melanoma Chemoprevention in Skin Reconstructs and Mouse Xenografts Using Isoselenocyanate-4

(2010) N. Nguyen et al.   Cancer Prevention Research

Nutrition and melanoma prevention

(2010) J. Daniel Jensen et al.   CLINICS IN DERMATOLOGY

Synthesis and Biological Evaluation of Triazol-4-ylphenyl-Bearing Histone Deacetylase Inhibitors as Anticancer Agents

(2010) Rong He et al.   JOURNAL OF MEDICINAL CHEMISTRY

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

(2010) Keith T. Flaherty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

SelSA, selenium analogs of SAHA as potent histone deacetylase inhibitors

(2009) Dhimant Desai et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Histone deacetylase inhibitors as anti-neoplastic agents

(2009) Nicolas Batty et al.   CANCER LETTERS

HDACi – Targets beyond chromatin

(2009) Marc Buchwald et al.   CANCER LETTERS

Targeting Akt3 Signaling in Malignant Melanoma Using Isoselenocyanates

(2009) A. Sharma et al.   CLINICAL CANCER RESEARCH

Clinical Studies of Histone Deacetylase Inhibitors

(2009) H. M. Prince et al.   CLINICAL CANCER RESEARCH

Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders

(2009) Norbert Wiech et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Melanoma Epidemiology and Public Health

(2009) Marianne Berwick et al.   DERMATOLOGIC CLINICS

Histone deacetylase inhibitors: Potential in cancer therapy

(2009) P.A. Marks et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Potential Role of Sirtuin as a Therapeutic Target for Neurodegenerative Diseases

(2009) Seol-Heui Han   Journal of Clinical Neurology

Histone Deacetylase Inhibitors in Cancer Therapy

(2009) Andrew A. Lane et al.   JOURNAL OF CLINICAL ONCOLOGY

New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer

(2009) Shundong Cang et al.   Journal of Hematology & Oncology

Skin Cancer: New Markers for Better Prevention

(2009) Rüdiger Greinert   PATHOBIOLOGY

The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma

(2009) SubbaRao V. Madhunapantula et al.   Pigment Cell & Melanoma Research

Targeting V600EB-Raf and Akt3 Using Nanoliposomal-Small Interfering RNA Inhibits Cutaneous Melanocytic Lesion Development

(2008) M. A. Tran et al.   CANCER RESEARCH

Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer

(2008) Olaia Martínez-Iglesias et al.   Clinical & Translational Oncology

BRAF kinase in melanoma development and progression

(2008) Amena M. DeLuca et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

PBISe, a novel selenium-containing drug for the treatment of malignant melanoma

(2008) S. V. Madhunapantula et al.   MOLECULAR CANCER THERAPEUTICS